Searched for
PHARMEASY FOUNDERS
Nandan Nilekani's Fundamentum bets big on AI, deeptech with Rs 3,000 crore purseFundamentum Partnership has launched F2A, a Rs 3,000 crore frontier-tech investment platform focused on AI and deeptech startups. The firm ...- FirstCry, Slice’s FY26 numbers; Nilekani’s Fundamentum eyes deeptech pushFirstCry parent cut its losses in the March quarter on tightened costs. This and more in today's ETtech Top 5.
- Mother's Day Special: How AI, apps are empowering women to manage finances, improve health, build careerWomen are learning to keep pace with the ubiquitous apps and AI, shrugging off dependence on their kids for financial transactions, online ...
- Pharmacy startup Plazza in talks to raise $12-15 million from Accel, Nexus, ElevationPlazza, a quick medicine delivery startup, is in talks to secure $12-15 million in funding. This new capital will help Plazza expand its ph...
- Pharmeasy founder Siddharth Shah steps down as CEOPharmeasy founder Siddharth Shah has stepped down as the chief executive to assume the role of vice chairman of the company's board. Rahul ...
- PharmEasy founders make interior design and architecture foray with All HomeThree of PharmEasy's founders — Dharmil Sheth, Dhaval Shah, and Hardik Dedhia — have launched All Home, an architectural and interior desig...
- PharmEasy CEO has three-year lock-in, Ranjan Pai to get three board seatsPai is also joining the board of PharmEasy and is expected to work with CEO Shah. He will retain the board seats as long as his holding doe...
- ETtech Explainer: What are down rounds and will they become the norm for Indian startups?A down round is when a privately held firm raises funds at a valuation lower than that ascribed in the previous round.
- PharmEasy valuation crash may not hit Thyrocare founder Velumani’s stakePharmEasy is faced with a steep cut in its valuation, with the new funding round pegging its shares at Rs 5 each compared to the Rs 50 per ...
- Exclusive: PharmEasy plans Rs 2,400-crore rights issue at 90% discount to repay loanMumbai-based epharmacy platform PharmEasy is likely to be valued at $500-600 million compared to the $5.6 billion valuation in 2021
- Exclusive | Not selling Thyrocare, will cut cash burn: PharmEasy founders to boardPharmEasy’s parent API Holdings has also delayed internal plans for a potential initial public offering (IPO) to 2025, the people privy to ...
- PharmEasy closes pre-IPO funding round at $5.6 billion valuationPharmEasy founders — Siddharth Shah, Dhaval Shah, Dhramil Sheth, Harsh Parekh and Hardik Dedhia — have received new stock options ahead of ...
- Exclusive: New investors in talks to join PharmEasy’s pre-IPO funding roundThe company has also finalised a secondary transaction of around $100 million in which some existing investors, such as Infosys cofounder N...
- PharmEasy acquires Aknamed in $180-$190 million stock dealThe acquisition, which is similar to its purchase of Thyrocare in June, is part of the Mumbai-based company’s plans to position itself as a...
- Pre-IPO bout to value PharmEasy at $6 billionTalks on with Amansa, Blackstone, OrbiMed and others as e-pharmacy eyes IPO at $7-8 billion valuation.
- Pharmeasy in funding talks with SoftBank after Thyrocare dealPharmeasy’s parent API Holdings is seeking a valuation of at least $5.6 billion in a new funding round. SoftBank could invest $150 million ...
- PharmEasy completes acquisition of MedlifeThe company has now become the largest healthcare delivery platform across the country, catering to more than two million families every si...
- Prosus in talks to put $200 million into PharmEasyProsus is expected to get a double-digit stake in PharmEasy's parent. Private equity major TPG Capital is also picking up about 7% stake in...
- PharmEasy appoints Abhinav Yajurvedi as the Chief Technology OfficerYajurvedi's past stints has been with Myntra, Amazon and Trilogy.
- PharmEasy and Brand Capital create India's No.1 Health Tech platformIn 2015, two young Mumbaikars had a dream. A dream to connect patients to local pharmacies and diagnostic centres through a mobile app. The...
Load More
